Aarey Drugs Approaches All‑Time High: A Signal of Strength?

Aarey Drugs & Pharmaceuticals Ltd is trading close to its 52‑week high of around ₹72.75 on the NSE/BSE, with its recent price hovering just a touch below that mark. Compared to its 52‑week low of ~₹31.30, the stock has nearly doubled, reflecting strong recovery and investor interest. Financials show mixed signals: while net profit rose 10.5% in the June 2025 quarter compared to a year earlier, sales dropped by nearly 19.5%. Also, the company is currently trading at high valuations (P/E ~47.6×), which increases expectations and risk. In technical terms, the recent move near the 52‑week high suggests demand zone. Key resistance lies just above current levels, while the stock has decent demand around the ₹65‑₹67 range. Investors may see this as an opportunity, but should be mindful of both upside potential and the possibility of profit‑booking near overheated levels. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile. please read full disclosure disclaimer in given link *****